Results 81 to 90 of about 1,745 (114)

Potential value of [<sup>68</sup>Ga]Ga-FAPI-46 PET in patients with metastatic urothelial carcinoma: a bi-centric analysis. [PDF]

open access: yesEur J Nucl Med Mol Imaging
Pabst KM   +17 more
europepmc   +1 more source

<sup>68</sup>Ga-FAPI-PET/CT in extra-cervical CUP: Head-to-Head Comparison of <sup>68</sup>Ga-FAPI-46 with <sup>18</sup>F-FDG in 13 patients. [PDF]

open access: yesEur J Nucl Med Mol Imaging
Spektor AM   +14 more
europepmc   +1 more source

[<sup>68</sup>Ga]Ga-FAPI-46 PET/CT of Patients with Gastrointestinal Stromal Tumors in Comparison to 2-[<sup>18</sup>F]FDG PET/CT and Contrast-Enhanced CT: Results from a Prospective Observational Study. [PDF]

open access: yesJ Nucl Med
Bartel T   +12 more
europepmc   +1 more source

Spatial FAP Expression as Detected by 68 Ga-FAPI-46 Identifies Myofibroblasts Beyond the Infarct Scar After Reperfusion. [PDF]

open access: yesMol Imaging Biol
Hess A   +11 more
europepmc   +1 more source

Evaluating [<sup>225</sup>Ac]Ac-FAPI-46 for the treatment of soft-tissue sarcoma in mice. [PDF]

open access: yesEur J Nucl Med Mol Imaging
Taddio MF   +14 more
europepmc   +1 more source

68Ga-FAPI-46 PET/CT in the evaluation of gliomas: comparison with 18F-FDG PET/CT and contrast-enhanced MRI. [PDF]

open access: yesTheranostics
Ruan D   +12 more
europepmc   +1 more source

Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with <sup>213</sup>Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic Tumors. [PDF]

open access: yesJ Nucl Med
Helisch A   +14 more
europepmc   +1 more source

Diagnostic Potential of Supplemental Static and Dynamic <sup>68</sup>Ga-FAPI-46 PET for Primary <sup>18</sup>F-FDG-Negative Pulmonary Lesions. [PDF]

open access: yesJ Nucl Med
Röhrich M   +19 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy